Table 2.

Association of HCV serostatus with the outcome of wait-listing for kidney transplantation, in a multivariable model with clustering on donor service area

Characteristic	Death Censored (n=388,437)		Death as a Competing Risk (n=388,437)
HCV-seropositive	0.67 (0.61–0.74)		0.67	0.61–0.74
Age
<40 y	1.00 (reference)		1.00 (reference)
40–70 y	0.56	0.53–0.59	0.51	0.48–0.54
>70 y	0.06	0.05–0.07	0.05	0.04–0.06
Male sex	1.33	1.30–1.37	1.33	1.30–1.37
Race
Caucasian	1.00 (reference)		ref	ref
African American	0.85	0.79–0.92	0.96	0.89–1.03
Asian	1.30	1.06–1.59	1.49	1.25–1.78
Latino	0.80	0.62–1.02	0.92	0.73–1.16
Other	1.01	0.90–1.13	1.13	1.01–1.26
Dialysis Modality
Hemodialysis	ref	ref	ref	ref
Home Hemodialysis	1.35	1.16–1.56	1.39	1.17–1.64
Nocturnal	1.45	1.22–1.72	1.45	1.25–1.69
Peritoneal dialysis	1.71	1.59–1.84	1.78	1.66–1.92
Insurance
Medicare	ref	ref	ref	ref
Medicaid	0.75	0.69–0.82	0.73	0.67–0.80
Private	1.49	1.32–1.70	1.49	1.32–1.68
Cardiovascular disease	0.79	0.75–0.83	0.78	0.74–0.82
Diabetes mellitus	0.78	0.74–0.82	0.77	0.73–0.81
Liver disease	1.00	0.90–1.11	0.94	0.84–1.05
COPD	0.46	0.42–0.52	0.43	0.38–0.48
Income quintile
$8,993–35,363	ref	ref	ref	ref
$35,370–43,265	1.09	1.01–1.17	1.08	0.99–1.16
$43,331–52,143	1.18	1.04–1.33	1.16	1.04–1.31
$52,173–67,316	1.31	1.18–1.45	1.31	1.19–1.44
$67,331–180,120	1.45	1.27–1.66	1.45	1.27–1.66
Albumin < 3.5 g/dl	0.86	0.84–0.89	0.75	0.73–0.78
Hemoglobin
<10 g/dL	1.35	1.29–1.41	1.27	1.22–1.33
10–12 g/dL	1.16	1.13–1.20	1.11	1.08–1.14
>12 g/dl	ref	ref	ref	ref
Platelets <150 × 103/mm3	0.79	0.77–0.83	0.69	0.66–0.72

Values shown are adjusted hazard ratio (95% confidence interval).

Abbreviations: COPD – chronic obstructive pulmonary disease; BMI – body mass index; AVF – arteriovenous fistula; AVG – arteriovenous graft; CVC – central venous catheter; PD – peritoneal dialysis; PRA – panel reactive antibody